2007
DOI: 10.1007/s11243-007-0207-5
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, characterization and RNA-binding properties of a novel ruthenium(II) complex coordinated by 5-pyridine-10,15,20-triphenylporphyrin

Abstract: A novel ruthenium(II) complex, [dibipyridyl-(5-pyridine-10,15,20-tri-phenylporphyrin)] ruthenium(II) chloride, (1), has been synthesized and characterized by elementary analyzing, ESI-MS and 13 C-NMR, as well as spectroscopy. The electronic spectra and emission spectra have been utilized to study the interaction of this ruthenium(II) complex (1) with the total RNA of liver cells, and the results show that there was obviously hypochromism and a red shift was observed for the Soret absorption and IL transition i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
15
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 12 publications
(16 citation statements)
references
References 25 publications
1
15
0
Order By: Relevance
“…In contrast to DNA, very small attention has been paid to the binding properties of RNA with transition metal complexes. Plenty of work pertaining to the RNA-binding properties [6][7][8], catalysts of RNA hydrolysis cleavage [9], shape-selective probes of RNA tertiary structure [10], agents of RNA oxidation cleavage [11], and approval of mismatches in RNA [12,13] has also been reported, but the RNA-binding properties of surfactant copper(II) complexes remain very fragmentary as compared to their DNA binding studies. To deeply understand the RNA-binding properties and concede important fundamental data for RNA-targeting drugs, much work is required.…”
Section: Introductionmentioning
confidence: 99%
“…In contrast to DNA, very small attention has been paid to the binding properties of RNA with transition metal complexes. Plenty of work pertaining to the RNA-binding properties [6][7][8], catalysts of RNA hydrolysis cleavage [9], shape-selective probes of RNA tertiary structure [10], agents of RNA oxidation cleavage [11], and approval of mismatches in RNA [12,13] has also been reported, but the RNA-binding properties of surfactant copper(II) complexes remain very fragmentary as compared to their DNA binding studies. To deeply understand the RNA-binding properties and concede important fundamental data for RNA-targeting drugs, much work is required.…”
Section: Introductionmentioning
confidence: 99%
“…This interest is due to the unique physical properties of these complexes and their potential applications in biology. In particular, the potential application of these complexes in the design and development of synthetic restriction enzymes, new drugs, DNA footprinting agents and stereoselective probes of nucleic acid structure has been explored extensively . However, there are few reports pertaining to interactions between transition metal complexes and transfer RNA (tRNA) .…”
Section: Introductionmentioning
confidence: 99%
“…In particular, the potential application of these complexes in the design and development of synthetic restriction enzymes, new drugs, DNA footprinting agents and stereoselective probes of nucleic acid structure has been explored extensively . However, there are few reports pertaining to interactions between transition metal complexes and transfer RNA (tRNA) . The future development of tRNA‐targeting drugs relies on a deeper understanding of these binding processes, leading to advances in medical applications, such as the inhibition of HIV and photodynamic therapy for tumours .…”
Section: Introductionmentioning
confidence: 99%
“…These metal complexes have been used as catalysts of RNA hydrolysis cleavage [12], shape-selective probes of RNA tertiary structure [13], agents of RNA oxidation cleavage [14] and for recognition of mismatches in RNA [15]. But only a few reports have investigated the interactions between transition metal complexes and RNA [16][17][18]. The future development of RNA-targeting drugs will rely on a deeper understanding of these binding processes, leading to advances in medical applications such as the inhibition of the AIDS virus and the photodynamic therapy of tumours [19].…”
Section: Introductionmentioning
confidence: 99%